EGESTA - Emergent GI Therapy for Severe, Complicated CDI Using Fecal Microbiota Transplant (EGESTA)
This study has been withdrawn prior to enrollment.
(Lack of eligible patients)
Milton S. Hershey Medical Center
First Posted: November 18, 2016
Last Update Posted: November 27, 2017
Information provided by (Responsible Party):
David B. Stewart, MD, FACS, FASCRS, Milton S. Hershey Medical Center
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Study Completion Date:||November 14, 2017|
|Primary Completion Date:||November 14, 2017 (Final data collection date for primary outcome measure)|